These mutations can produce alterations in the protein’s structure that affect its functionality; the mutant allele could have a dominant negative effect over the wild type allele, causing serious consequences for carrier patients as have been described by John et al [41] in the BMPR2 gene in patients with PAH. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.